series-c-plus
Stage
3
Investors
About
Prostatype Genomics develops and commercializes a prognostic gene test for prostate cancer that helps clinicians and patients make informed treatment decisions by assessing the aggressiveness of the cancer.
Explore Prostatype Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.